Lenalidomide, a novel analogue of thalidomide, belongs to the immunomodulatory drug (IMiD) for the treatment of multiple myeloma and myelodysplastic syndrome.

来那度胺是一种新型免疫调节药,主要用于治疗多发性骨髓瘤和骨髓增生异常综合征。